
Editors’ Picks, September 2024: Reducing Pancreatic Cancer Risk, Immunotherapy for Dogs, and More
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
For World Cancer Research Day, AACR convened a panel of experts to discuss how they are helping to drive...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
A recap of the plenary sessions, cutting-edge science, clinical trials, and more covered by the AACR blog.
The editors of AACR's journals highlight studies from May, including machine learning, savings from quitting smoking, and more.
Experience the annual undergraduate poster competition at the AACR Annual Meeting through photos.